No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.

Similar Items

• No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
  by: Hopewell, J, et al.
  Published: (2011)
• No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
  by: Hopewell, J, et al.
  Published: (2009)
• Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
  by: Heart Protection Study Collaborative Group
  Published: (2007)
• Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
  by: Heart Protection Study Collaborative Group
  Published: (2010)
• N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
  by: Emberson, JR, et al.
  Published: (2007)